These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 6771653)
1. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653 [TBL] [Abstract][Full Text] [Related]
2. Prothrombin complex concentrates in hemophiliacs with inhibitors--a multicenter therapeutic trial. Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM Trans Assoc Am Physicians; 1980; 93():175-81. PubMed ID: 6787773 [No Abstract] [Full Text] [Related]
3. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial. Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990 [TBL] [Abstract][Full Text] [Related]
5. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies. Buchanan GR; Kevy SV Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319 [TBL] [Abstract][Full Text] [Related]
6. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies. Blatt PM; Ménaché D; Roberts HR Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386 [TBL] [Abstract][Full Text] [Related]
7. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients. Prentice CR Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428 [No Abstract] [Full Text] [Related]
8. Treatment of inhibitor patients with activated prothrombin complex concentrates. Penner JA Prog Clin Biol Res; 1984; 150():291-308. PubMed ID: 6431434 [TBL] [Abstract][Full Text] [Related]
9. Treatment of anti-factor VIII antibodies. Blatt PM; White GC; McMillan CW; Roberts HR Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493 [TBL] [Abstract][Full Text] [Related]
10. Hemophiliacs with inhibitors: therapeutic options. Roberts HR N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992 [No Abstract] [Full Text] [Related]
11. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor]. Klukowska A; Zieleniewska B Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036 [TBL] [Abstract][Full Text] [Related]
12. The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors. Lusher JM Scand J Haematol Suppl; 1984; 40():195-202. PubMed ID: 6433452 [No Abstract] [Full Text] [Related]
13. Increased fibrinopeptide A after prothrombin complex concentrates. Viganó S; Cattaneo M; Gervasoni W; Mannucci PM Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a heated prothrombin complex concentrate in hemophiliacs with inhibitors. Mannucci PM; Mari D; Pareti FI Thromb Haemost; 1987 Dec; 58(4):1090-1. PubMed ID: 3127920 [No Abstract] [Full Text] [Related]